A new study has found a possible new target for treating a type of Pediatric Blood Cancer called juvenile myelomonocytic leukemia. The study identified that dexamethasone, a commonly used anti-inflammatory drug, helped treat juvenile myelomonocytic leukemia in zebrafish.
